Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,779,467 papers from all fields of science
Search
Sign In
Create Free Account
fenclozic acid
Known as:
2-(4-chlorophenyl)-4--thiazoleacetic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
ICI 54450
Broader (1)
Thiazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid.
James A. Akingbasote
,
Alison J. Foster
,
+4 authors
J. G. Kenna
Toxicological Research
2017
Corpus ID: 51942189
Hepatic NADPH-cytochrome P450 oxidoreductase null (HRN™) mice exhibit no functional expression of hepatic cytochrome P450 (P450…
Expand
2014
2014
The metabolic fate of [14C]-fenclozic acid in the hepatic reductase null (HRN) mouse
K. Pickup
,
Jonathan Wills
,
+5 authors
I. Wilson
Xenobiotica; the fate of foreign compounds in…
2014
Corpus ID: 3107570
Abstract 1. The distribution, metabolism, excretion and hepatic effects of fenclozic acid were investigated following a single…
Expand
2014
2014
Identification of the reactive metabolites of fenclozic acid in bile duct cannulated rats.
Scott Martin
,
E. Lenz
,
W. Keene
,
M. Clench
Analytical Chemistry
2014
Corpus ID: 20707877
Fenclozic acid (Myalex) was developed by ICI pharmaceuticals in the 1960s for the treatment of rheumatoid arthritis and was a…
Expand
1983
1983
The fate of fenclozic acid in the gut and its effect on some aspects of gut metabolism.
C. Curtis
,
G. Powell
,
A. Bradbury
,
C. Rhodes
Xenobiotica; the fate of foreign compounds in…
1983
Corpus ID: 22579648
In the rat [14C]fenclozic acid is not metabolized in the gut and passes into the portal blood unchanged. After intraduodenal…
Expand
1981
1981
The enhanced biliary secretion of a taurine conjugate in the rat after intraduodenal administration of high doses of fenclozic acid.
A. Bradbury
,
G. Powell
,
C. Curtis
,
C. Rhodes
Xenobiotica; the fate of foreign compounds in…
1981
Corpus ID: 2087957
1. The metabolic fate of [14C]fenclozic acid (ICI 54450) in rat was determined after intraduodenal administration at different…
Expand
1979
1979
The effects of fenclozic acid on fertility of male rats.
W. Ratnasooriya
,
R. Wadsworth
Contraception
1979
Corpus ID: 26728269
1971
1971
Pharmacokinetics of fenclozic acid in animals and man.
D. S. Platt
Journal of Pharmacy and Science
1971
Corpus ID: 45693524
The pharmacokinetic properties of the anti-inflammatory agent, fenclozic acid, have been established in the dog, calf, sheep, and…
Expand
1969
1969
The pharmacology of fenclozic acid (2‐(4‐chlorophenyl)‐thiazol‐4‐ylacetic acid; I.C.I. 54, 450; ‘Myalex’); a new compound with anti‐inflammatory, analgesic and antipyretic activity
B. Newbould
British Journal of Pharmacology
1969
Corpus ID: 44400499
1 Fenclozic acid (2‐(4‐chlorophenyl)thiazol‐4‐ylacetic acid; I.C.I. 54, 450; “Myalex”) is one representative of a new class of…
Expand
1969
1969
Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis.
T. Chalmers
,
J. Kellgren
,
D. S. Platt
Annals of the Rheumatic Diseases
1969
Corpus ID: 6786220
Inthepharmacological evaluation ofanewdrug muchistobegained byclose co-operation between clinical andindustrial research…
Expand
1969
1969
Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.
T. Chalmers
,
J. Pohl
,
D. S. Platt
Annals of the Rheumatic Diseases
1969
Corpus ID: 35470727
Fenclozic acid (I.C.I. 54,450; 2-(p-chlorophenyl) thiazol-4-ylacetic acid; Myalex*) (Hepworth, Newbould, Platt, and Stacey, 1969…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE